Design and synthesis of non-hydrolyzable homoisoprenoid α-monofluorophosphonate inhibitors of PPAPDC family integral membrane lipid phosphatases.

Bioorg Med Chem Lett

Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536, USA; Markey Cancer Center, University of Kentucky, Lexington, KY 40536, USA; Kentucky Center for Structural Biology, University of Kentucky, Lexington, KY 40536, USA; Department of Chemistry, University of Kentucky, Lexington, KY 40536, USA. Electronic address:

Published: September 2014

An efficient, diversity oriented synthesis of homoisoprenoid α-monofluorophosphonates utilizing electrophilic fluorination is presented along with their activity as inhibitors of PPAPDC2 family integral membrane lipid phosphatases. These novel phosphatase-resistant analogues of isoprenoid monophosphates are a platform for further structure-activity relationship studies and provide access to other isoprenoid family members where the phosphate ester oxygen is replaced by a α-monofluoromethylene moiety.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206410PMC
http://dx.doi.org/10.1016/j.bmcl.2014.08.013DOI Listing

Publication Analysis

Top Keywords

family integral
8
integral membrane
8
membrane lipid
8
lipid phosphatases
8
design synthesis
4
synthesis non-hydrolyzable
4
non-hydrolyzable homoisoprenoid
4
homoisoprenoid α-monofluorophosphonate
4
α-monofluorophosphonate inhibitors
4
inhibitors ppapdc
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!